Sentry Page Protection

Member Profile Page

Bob Nelsen

Bob Nelsen.png

Transactions Sponsored:   2

Members Invited:              5


Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. He joined ARCH at its founding and played a significant role in the early sourcing, financing and development of more than thirty companies, including fifteen which have reached valuations exceeding $1 billion.

Mr. Nelsen is a director of Agios Pharmaceuticals, Juno Therapeutics, Denali Therapeutics, Sage Therapeutics, Arivale, Syros Pharmaceuticals, and serves as Chairman of Hua Medicine, among others. He previously served as a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute for Systems Biology, and as a director of the National Venture Capital Association.

Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. from the University of Puget Sound with majors in Economics and Biology.


Member Connections

Dave Marver

Deals Sponsored

VICIS Series B

VICIS Convertible Note


 

Contact Bob Nelsen

Name *
Name
Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Log Out